During the past decade, Klinikum Ludwigsburg conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 6 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Ludwigsburg" #1 sponsor was "Kliniken Ludwigsburg-Bietigheim gGmbH" with 8 trials, followed by "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Ludwigsburg" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Klinikum Ludwigsburg" with 2 trials as a collaborator, "Ovesco Endoscopy AG" with 2 trials as a collaborator, "University Hospital Tuebingen" with 2 trials as a collaborator and "University Hospital Ulm" with 2 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Ludwigsburg" are "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Gastric Cancer" (3 trials), "Lymphoma" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Klinikum Ludwigsburg" in a lesser frequency.

Most popular intervention types in "Klinikum Ludwigsburg" are "Drug" (27 trials), "Device" (13 trials), "Procedure" (6 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abemaciclib" (3 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Ludwigsburg" are 43 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Ludwigsburg". undefined are not yet recruiting, 8 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Klinikum Ludwigsburg, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Ludwigsburg, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".